LC is doing a great job of communicating. We don’t need any more truck drivers etc who don’t understand the science. We’ve already got 28,000 shareholders who don’t understand the science . Most of the posters here don’t have a good grasp of what she is saying. She is a very intelligent person who is quite efficient with her use of language. But many don’t listen. The people we want taking an interest are major investment funds and Big Pharma. For those who have been listening to the company, they have been loudly and clearly trumpeting what is happening.
They are on the cusp of making major News announcements. That was clearly flagged back in February. And again in July. November SITC IS THE VENUE . Those people expecting Complete response numbers, and partial response and progression free survival data will be disappointed. That won’t get released till the data is compiled and analysed by independent auditors. And approved by the FDA. Next May or June 2024.
This SITC can give a science update. The mechanism of action. Etc.. We can expect to see Scans showing, CF33 infecting Solid Tumors. HNIS in action. And scans show reduction in Tumor size. And Pathology reports showing dead tumor cells. And Pathology Blood tests showing anti-body responses to the CF33, show that the body’s immune system is awake and alert to the cancerous Tumors. That’s CD4 and CD8 antibodies etc. this will be the second paper showing antibody response in human trials.
That’s the type of scientific update that can be released. Not results from the trial. Just scientific evidence of how the CF33 Vaxinia actually operates in the human body. Evidence that Vaxinia turns cold tumors into hot tumors. This will still be a world first, First in class. And at this point best in class.
Remember again that PH said “ We have done considerable work towards a Nasdaq listing. But it won’t happen till after we have a major event”
Remember LC SAYING “ I don’t want to steal YF’s thunder”
Remember YF saying “ They have just accepted the biopsies analysis of the tumor samples for a major conference. Just Yesterday”
If shareholders have been taking notice when IMU has news they generally go quiet for a period before hand and then ramp up media exposure. That’s happening now. LC has just said she is bringing out our new 2 new senior US based executives to visit trials sites and maybe meet with shareholders. They’ve got news to share.
If any shareholders want to know what’s happening try listening to the company. IMU are “FIRST IN CLASS AND BEST IN CLASS”. For CarT and for Oncoviruses. Two cutting edge Cancer treatments, IMU are the only company in the world that has technology for Killing Cancers in Solid Tumors.
They are just about to show the world what they’ve got., LC always said “ we will announce our science at Prestigious Conferences “
Im dumbfounded that so many shareholders can’t understand these simple statements the company makes. Even Nick EDES gave a very specific clue to timing. “This is a 12 month play”.
Another 28,000 truck drivers buying shares here is not the path to success. “FOLLOW THE SCIENCE”
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-10477
-
-
- There are more pages in this discussion • 4,671 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.5¢ |
Change
0.003(5.77%) |
Mkt cap ! $389.5M |
Open | High | Low | Value | Volume |
5.3¢ | 5.5¢ | 5.2¢ | $260.2K | 4.860M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 1680950 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 1356155 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 589000 | 0.054 |
13 | 905829 | 0.053 |
29 | 2256098 | 0.052 |
41 | 5307570 | 0.051 |
54 | 4355079 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 1323652 | 19 |
0.056 | 3144581 | 13 |
0.057 | 1011639 | 12 |
0.058 | 1405490 | 12 |
0.059 | 2307708 | 12 |
Last trade - 12.08pm 20/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |